Practical approaches to treating patients with acute decompensated heart failure

Journal of Cardiac Failure

Volumn 7, Issue 2 PART II, 2001, Pages 13-17

  Maisel, Alan S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

B type natriuretic peptide; Congestive heart failure; Diastolic dysfunction

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DIAGNOSTIC AGENT;

ACUTE DISEASE; BLOOD; CONGESTIVE HEART FAILURE; HOSPITAL INFORMATION SYSTEM; HUMAN; PREDICTION AND FORECASTING; REVIEW;

ACUTE DISEASE; ATRIAL NATRIURETIC FACTOR; HEART FAILURE, CONGESTIVE; HUMANS; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS;

EID: 0035378410     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2001.26646     Document Type: Article

References (11)

1. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amrinovin R, Lenert L, Clopton P, Albert J, Hlavin P, Maisel AS: Utility of B-type natriuretic peptide (BNP) in the diagnosis of CHF in an urgent care setting. J Am Coll Cardiol 2000;37:379-385
2. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T: Early readmission of elderly patients with heart failure. J Am Geriatr Soc 1990;38:1290-1295
3. Adams KF: Post hoc subgroup analysis and the truth of a clinical trial. Am Heart J 1998;136:751-758
4. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH, Rudin-Toretsky E, Yusuf S: Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 1990;82:1724-1729
5. Remes J, Tikkanen I, Fyhriquist F, Ryoarala K: Neuroendocrine activity in untreated heart failure. Br Heart J 1991;65:249-255
6. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, for the Consensus Trial Study Group: Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990;82:1730-1736
7. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M: Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509-516
8. Maeda K, Takayoshi T, Wada A, Hisanaga T, Kinoshita M: Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-832
9. Cheng VL, Krishnaswamy P, Kazanegra R, Garcia A, Gardetto N, Maisel AS: A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure. J Am Coll Cardiol 2001;37:386-391
10. Kazanagra R, Chen V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P, Maisel AS: A rapid test for B-type natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 2001;7:21-29
11. Richards AM, Doughty R, Nicholls MG, Macmahon S, Ikram H, Sharpe N, Espiner EA, Frampton C, Yandle TG, for the Australia-New Zealand Heart Failure Group: Neurohumoral predictors of benefit from carvedilol in ischemic left ventricular dysfunction. Circulation 1999; 99:786-797